Background: Atopic dermatitis (AD) is a chronic inflammatory skin condition that is closely associated with an imbalance in the skin microbiome. This imbalance, also known as dysbiosis, leads to the overgrowth of pathogenic microorganisms, particularly Staphylococcus aureus, while beneficial bacteria such as Staphylococcus epidermidis are diminished. The relationship between the microbiome and the immune system plays a crucial role in the pathogenesis and progression of AD. Objective: The aim of this article is to review the role of the skin microbiome in the development and management of atopic dermatitis. The article explores microbial composition, dysbiosis, immune interactions, environmental and genetic factors, and current therapeutic strategies. Methods: A comprehensive review of recent studies was conducted to evaluate the impact of the skin microbiome on AD. The review focuses on microbial shifts, the role of S. aureus, immune system interactions, and potential treatments targeting the skin microbiome. Results: The findings highlight that microbial dysbiosis, particularly the dominance of S. aureus, contributes to the severity of AD. Therapeutic approaches targeting the microbiome, such as the use of probiotics, prebiotics, antimicrobial peptides, and microbiome transplants, show promise in managing AD symptoms. Conclusion: The skin microbiome plays a critical role in the pathogenesis of atopic dermatitis. Restoring microbial balance through targeted therapies could offer new avenues for effective treatment and management of AD.